# An Efficacy and Safety Study of Transdermal Therapeutic System (TTS)-Fentanyl in Severe Chronic Low Back Pain

> **NCT01774903** · PHASE4 · COMPLETED · sponsor: **Janssen-Cilag Ltd.,Thailand** · enrollment: 45 (actual)

## Conditions studied

- Low Back Pain

## Interventions

- **DRUG:** TTS-fentanyl

## Key facts

- **NCT ID:** NCT01774903
- **Lead sponsor:** Janssen-Cilag Ltd.,Thailand
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-08
- **Primary completion:** 2009-06
- **Final completion:** 2009-06
- **Target enrollment:** 45 (ACTUAL)
- **Last updated:** 2013-03-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01774903

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01774903, "An Efficacy and Safety Study of Transdermal Therapeutic System (TTS)-Fentanyl in Severe Chronic Low Back Pain". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01774903. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*